Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04462458
Other study ID # P07.001.01
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date July 1, 2022
Est. completion date January 2027

Study information

Verified date March 2023
Source Medacta International SA
Contact Denise Falcone
Phone +41916966060
Email falcone@medacta.ch
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The goal of this study is to evaluate the performance of Medacta Anatomic Ribbon Surgery (M-ARS) in patients requiring anterior cruciate ligament (ACL) reconstruction. The main goal is to evaluate the survival rate of M-ARS ACL at 6 months post-operatively. The secondary goals are to assess the survival rate, clinical and functional outcomes, the quality of life, and the rate of complications at 1 month, 1 year and 2 years post-operatively.


Description:

This s a prospective, multicenter, non-controlled, observational study to evaluate the outcomes of Medacta Anatomic Ribbon Surgery (M-ARS) in the reconstruction of the anterior cruciate ligament (ACL). Participants will be informed about the study, both orally and in writing, during a preoperative visit. The investigator will answer any questions that may arise and will collect the informed consent. During the study, enrolled participants will be able to withdraw at any time and for any reason. The study is conducted according to the following schedule: - V1 : Inclusion during a preoperative visit - V2: Surgery - V3: Follow-up visit at 1 month ± 15 days post-surgery - V4: Follow-up visit at 6 months ± 30 days post-surgery - V5: Follow-up visit at 12 months ± 60 days post-surgery - V6: Follow-up visit at 24 months ± 90 days post-surgery The following data will be collected: - Survival rate of implants evaluating the incidence of implants failure, where implant failure is defined as revision, loosening, or any definite change in the position of components (V3-V6). - Clinical and functional outcomes, measured with the International Knee Documentation Committee (IKDC) score (V1, V3-V6) - Quality of Life, measured with the EQ-5D score (V1, V3-V6) - Occurrence of intraoperative and postoperative complications (V2-V6) Depending on standard practice, imaging assessment of implants and bone tunnels may be performed. A web-based data collection tool will be used as Electronic Data Capture (EDC). All the information required by the protocol will be collected in electronic case report forms (eCRF). The statistical analysis will be performed according to a pre-established statistical analysis plan. Missing values will not be replaced by estimated values but will be considered as missing in the statistical analysis.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date January 2027
Est. primary completion date July 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients older than 18 years - Patients with ACL rupture requiring ACL reconstruction Exclusion Criteria: - Patients with malignant diseases (at the time of surgery) - Patients with proven or suspected infections (at the time of surgery) - Patients with functional deficits of the affected extremity (at the time of surgery) - Patients with known incompatibility or allergy to products materials (at the time of surgery)

Study Design


Related Conditions & MeSH terms

  • Anterior Cruciate Ligament (ACL) Reconstruction

Intervention

Device:
Medacta Anatomic Ribbon Surgery (M-ARS ACL)
M-ARS ACL allows to reconstruct the anterior cruciate ligament using the Anatomic Ribbon Technique

Locations

Country Name City State
Austria Praxis Gelenkpunkt - Sport- und Gelenkchirurgie Innsbruck
Austria Pyhrn-Eisenwurzen Klinikum Kirchdorf Kirchdorf An Der Krems
Germany OCM Klinik GmbH München

Sponsors (1)

Lead Sponsor Collaborator
Medacta International SA

Countries where clinical trial is conducted

Austria,  Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Survival rate Kaplan Meier method 6 months
Secondary Survival rate Kaplan Meier method 1, 12, 24 months
Secondary Functional outcome International Knee Documentation Committee (IKDC) score 1, 6, 12, 24 months
Secondary Quality of Life outcome EQ-5D score 1, 6, 12, 24 months
Secondary Radiological outcome (optional) Evaluation of ligament osteointegration, femoral/tibial tunnel widening, presence of fluid in the femoral/tibial tunnel 1, 6, 12, 24 months
Secondary Complication rate Occurrence of intraoperative and postoperative complications intraoperative, 1, 6, 12, 24 months
See also
  Status Clinical Trial Phase
Completed NCT03417479 - Gabapentin Premedication for ACL Reconstruction: RCT
Withdrawn NCT03562299 - OrthoPure™ XT Pilot Clinical Study N/A
Completed NCT03211728 - Does Perioperative Pregabalin Reduce Postoperative Pain After Arthroscopic Anterior Cruciate Ligament Reconstruction Surgery Under Spinal Anesthesia? N/A
Recruiting NCT06382324 - The Psychological Impact of Mindfulness Intervention to Anterior Cruciate Ligament Reconstruction N/A
Recruiting NCT06347523 - VR-Based Preoperative Rehabilitation Program for Patients Undergoing Anterior Cruciate Ligament (ACL) Reconstruction N/A